Paulissen J - Search Results

1

A High-Throughput Yellow Fever Neutralization Assay.

Rasulova M, Vercruysse T, Paulissen J, Coun C, Suin V, Heyndrickx L, Ma J, Geerts K, Timmermans J, Mishra N, Li LH, Kum DB, Coelmont L, Van Gucht S, Karimzadeh H, Thorn-Seshold J, Rothenfußer S, Ariën KK, Neyts J, Dallmeier K, Thibaut HJ. Rasulova M, et al. Among authors: paulissen j. Microbiol Spectr. 2022 Jun 29;10(3):e0254821. doi: 10.1128/spectrum.02548-21. Epub 2022 Jun 7. Microbiol Spectr. 2022. PMID: 35670599 Free PMC article.

2

Rational modifications, synthesis and biological evaluation of new potential antivirals for RSV designed to target the M2-1 protein.

Ferla S, Manganaro R, Benato S, Paulissen J, Neyts J, Jochmans D, Brancale A, Bassetto M. Ferla S, et al. Among authors: paulissen j. Bioorg Med Chem. 2020 Apr 15;28(8):115401. doi: 10.1016/j.bmc.2020.115401. Epub 2020 Feb 26. Bioorg Med Chem. 2020. PMID: 32143992

3

Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom.

Zeevat F, Luttjeboer J, Paulissen JHJ, van der Schans J, Beutels P, Boersma C, Postma MJ; RESCEU Investigators. Zeevat F, et al. Among authors: paulissen jhj. J Infect Dis. 2022 Aug 12;226(Suppl 1):S102-S109. doi: 10.1093/infdis/jiab118. J Infect Dis. 2022. PMID: 34522947 Free PMC article.

4

Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands.

Quist SW, van Schoonhoven AV, Bakker SJL, Pochopień M, Postma MJ, van Loon JMT, Paulissen JHJ. Quist SW, et al. Among authors: paulissen jhj. Cardiovasc Diabetol. 2023 Nov 28;22(1):328. doi: 10.1186/s12933-023-02053-6. Cardiovasc Diabetol. 2023. PMID: 38017448 Free PMC article.

5

Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE Sustain.

Allegretti JR, Gecse KB, Chiorean MV, Argollo M, Guo X, Lawendy N, Su C, Mundayat R, Paulissen J, Salese L, Irving PM. Allegretti JR, et al. Among authors: paulissen j. J Gastroenterol Hepatol. 2024 Feb;39(2):264-271. doi: 10.1111/jgh.16386. Epub 2023 Nov 12. J Gastroenterol Hepatol. 2024. PMID: 37953548

6

Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program.

Rubin DT, Salese L, Cohen M, Kotze PG, Woolcott JC, Su C, Mundayat R, Paulissen J, Torres J, Long MD. Rubin DT, et al. Among authors: paulissen j. Therap Adv Gastroenterol. 2023 Aug 7;16:17562848231189122. doi: 10.1177/17562848231189122. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37560161 Free PMC article.

7

Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland.

Paulissen JHJ, Seddik AH, Dunton KJ, Livings CJ, van Hulst M, Postma MJ, de Jong LA, Freriks RD. Paulissen JHJ, et al. Eur J Health Econ. 2023 Jul 24. doi: 10.1007/s10198-023-01617-3. Online ahead of print. Eur J Health Econ. 2023. PMID: 37486557

8

Costs of radium-223 and the pharmacy preparation ¹⁷⁷Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals.

Quist SW, Paulissen JHJ, Wyndaele DNJ, Nagarajah J, Freriks RD. Quist SW, et al. Among authors: paulissen jhj. J Med Econ. 2023 Jan-Dec;26(1):366-375. doi: 10.1080/13696998.2023.2183618. J Med Econ. 2023. PMID: 36905581 Free article.

9

Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore.

Lee SD, Allegretti JR, Steinwurz F, Connelly SB, Lawendy N, Paulissen J, Gecse KB. Lee SD, et al. Among authors: paulissen j. BMC Gastroenterol. 2023 Feb 8;23(1):34. doi: 10.1186/s12876-022-02508-2. BMC Gastroenterol. 2023. PMID: 36755231 Free PMC article. Clinical Trial.

10

Performance and usability evaluation of a mobile health data capture application in clinical cancer trials follow-up.

Paulissen JMJ, Zegers CML, Nijsten IR, Reiters PHCM, Houben RM, Eekers DBP, Roelofs E. Paulissen JMJ, et al. Tech Innov Patient Support Radiat Oncol. 2022 Nov 1;24:107-112. doi: 10.1016/j.tipsro.2022.10.005. eCollection 2022 Dec. Tech Innov Patient Support Radiat Oncol. 2022. PMID: 36387779 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page